Article Information
History
- November 5, 2021.
Article Versions
- Version 1 (July 2, 2021 - 04:00).
- Version 2 (July 11, 2021 - 09:55).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sara I. Taha1,*,
- Aalaa K. Shata2,
- Eman M. El-Sehsah3,
- Shaimaa H. Fouad4,
- Aya H. Moussa5,
- Shaimaa A. Abdalgeleel6,
- Nouran M. Moustafa7 and
- Mariam K. Youssef1
- 1Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.;
- 2Department of Pulmonary Medicine, Faculty of Medicine, Ain Shams university, Cairo, Egypt.;
- 3Department of Medical Microbiology and Immunology, Mansoura Faculty of Medicine, Mansoura, Egypt;
- 4Department of Internal Medicine / Allergy and Clinical Immunology, Ain Shams University, Cairo, Egypt.;
- 5Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt.;
- 6Department of Biostatistics and Epidemiology, National Cancer Institute, Cairo University, Cairo, Egypt.;
- 7Department of Basic Medical Science, Faculty of Medicine, Dar Al Uloom University, Riyadh, Saudi Arabia & Department of Microbiology and Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- ↵*Corresponding author; email: dr_sara_ib{at}med.asu.edu.eg
Posted November 05, 2021.
The Role of CRP, Interleukin-6 and Their Derived Immune-Inflammatory Indices in Early Prediction of Severity and Mortality of COVID-19 Patients
